Logo image of 1BAYN.MI

BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

BIT:1BAYN - Euronext Milan - DE000BAY0017 - Common Stock - Currency: EUR

29.11  +0.61 (+2.14%)

Fundamental Rating

3

Taking everything into account, 1BAYN scores 3 out of 10 in our fundamental rating. 1BAYN was compared to 53 industry peers in the Pharmaceuticals industry. 1BAYN has a bad profitability rating. Also its financial health evaluation is rather negative. 1BAYN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year 1BAYN was profitable.
In the past year 1BAYN had a positive cash flow from operations.
In multiple years 1BAYN reported negative net income over the last 5 years.
In the past 5 years 1BAYN always reported a positive cash flow from operatings.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -2.98%, 1BAYN is doing worse than 69.81% of the companies in the same industry.
1BAYN's Return On Equity of -10.03% is on the low side compared to the rest of the industry. 1BAYN is outperformed by 69.81% of its industry peers.
Industry RankSector Rank
ROA -2.98%
ROE -10.03%
ROIC N/A
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Operating Margin of 1BAYN has declined.
Looking at the Gross Margin, with a value of 53.99%, 1BAYN is doing worse than 69.81% of the companies in the same industry.
1BAYN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 1BAYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.99%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1BAYN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 1BAYN has about the same amount of shares outstanding.
1BAYN has a better debt/assets ratio than last year.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

Based on the Altman-Z score of 0.85, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.85, 1BAYN is not doing good in the industry: 73.58% of the companies in the same industry are doing better.
The Debt to FCF ratio of 1BAYN is 6.81, which is on the high side as it means it would take 1BAYN, 6.81 years of fcf income to pay off all of its debts.
1BAYN has a Debt to FCF ratio (6.81) which is in line with its industry peers.
1BAYN has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.08, 1BAYN is doing worse than 64.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 6.81
Altman-Z 0.85
ROIC/WACCN/A
WACC6.43%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.25 indicates that 1BAYN should not have too much problems paying its short term obligations.
1BAYN has a Current ratio of 1.25. This is in the lower half of the industry: 1BAYN underperforms 69.81% of its industry peers.
A Quick Ratio of 0.79 indicates that 1BAYN may have some problems paying its short term obligations.
1BAYN's Quick ratio of 0.79 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 64.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.79
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

3

3. Growth

3.1 Past

1BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.72%.
1BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
1BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -0.92%.
1BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-24.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-11.7%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-0.2%

3.2 Future

Based on estimates for the next years, 1BAYN will show a small growth in Earnings Per Share. The EPS will grow by 2.07% on average per year.
1BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.07% yearly.
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y2.07%
Revenue Next Year-0.13%
Revenue Next 2Y0.7%
Revenue Next 3Y1.06%
Revenue Next 5Y1.07%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.17, the valuation of 1BAYN can be described as very cheap.
96.23% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
1BAYN is valuated cheaply when we compare the Price/Earnings ratio to 28.05, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 5.90 indicates a rather cheap valuation of 1BAYN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BAYN indicates a rather cheap valuation: 1BAYN is cheaper than 98.11% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of 1BAYN to the average of the S&P500 Index (37.67), we can say 1BAYN is valued rather cheaply.
Industry RankSector Rank
PE 6.17
Fwd PE 5.9
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1BAYN is valued cheaper than 81.13% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.95
EV/EBITDA 7.65
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.15%
EPS Next 3Y1.51%

More info and screens

0

5. Dividend

5.1 Amount

1BAYN has a yearly dividend return of 0.39%, which is pretty low.
Compared to an average industry Dividend Yield of 3.03, 1BAYN is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.30, 1BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.39%

5.2 History

The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-4.03%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

BAYER AG-REG

BIT:1BAYN (7/25/2025, 7:00:00 PM)

29.11

+0.61 (+2.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners41.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.60B
Analysts71.72
Price Target28.84 (-0.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.39%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-4.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.63%
Min EPS beat(2)1.86%
Max EPS beat(2)3.41%
EPS beat(4)3
Avg EPS beat(4)-1.9%
Min EPS beat(4)-17.26%
Max EPS beat(4)4.42%
EPS beat(8)5
Avg EPS beat(8)-2.92%
EPS beat(12)8
Avg EPS beat(12)-2.14%
EPS beat(16)12
Avg EPS beat(16)1.92%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)1.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-2.63%
Revenue beat(12)4
Avg Revenue beat(12)-2.01%
Revenue beat(16)8
Avg Revenue beat(16)-0.66%
PT rev (1m)0.17%
PT rev (3m)4.56%
EPS NQ rev (1m)-1.8%
EPS NQ rev (3m)-11.87%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.77%
Revenue NQ rev (3m)-1.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 6.17
Fwd PE 5.9
P/S 0.61
P/FCF 4.95
P/OCF 3.36
P/B 0.88
P/tB N/A
EV/EBITDA 7.65
EPS(TTM)4.72
EY16.21%
EPS(NY)4.93
Fwd EY16.95%
FCF(TTM)5.88
FCFY20.21%
OCF(TTM)8.65
OCFY29.73%
SpS47.41
BVpS33.03
TBVpS-18.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.98%
ROE -10.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.99%
FCFM 12.41%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score3
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 6.81
Debt/EBITDA 4.37
Cap/Depr 30.76%
Cap/Sales 5.84%
Interest Coverage N/A
Cash Conversion 106.2%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.79
Altman-Z 0.85
F-Score3
WACC6.43%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-11.7%
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y2.07%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-0.2%
Revenue Next Year-0.13%
Revenue Next 2Y0.7%
Revenue Next 3Y1.06%
Revenue Next 5Y1.07%
EBIT growth 1Y-214.77%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.3%
EBIT Next 3Y21.17%
EBIT Next 5Y10.6%
FCF growth 1Y380.55%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y99.13%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%